Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $6.94 million. The enterprise value is -$13.59 million.
| Market Cap | 6.94M |
| Enterprise Value | -13.59M |
Important Dates
The last earnings date was Thursday, August 28, 2025, before market open.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GLMD has 5.46 million shares outstanding. The number of shares has increased by 403.44% in one year.
| Current Share Class | 5.46M |
| Shares Outstanding | 5.46M |
| Shares Change (YoY) | +403.44% |
| Shares Change (QoQ) | +121.85% |
| Owned by Insiders (%) | 1.19% |
| Owned by Institutions (%) | 4.60% |
| Float | 5.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.71
| Current Ratio | 8.71 |
| Quick Ratio | 8.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.52 |
Financial Efficiency
Return on equity (ROE) is -53.99% and return on invested capital (ROIC) is -27.19%.
| Return on Equity (ROE) | -53.99% |
| Return on Assets (ROA) | -24.21% |
| Return on Invested Capital (ROIC) | -27.19% |
| Return on Capital Employed (ROCE) | -34.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.51% in the last 52 weeks. The beta is 0.58, so GLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -60.51% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.08 |
| Relative Strength Index (RSI) | 34.04 |
| Average Volume (20 Days) | 234,302 |
Short Selling Information
| Short Interest | 62,814 |
| Short Previous Month | 46,319 |
| Short % of Shares Out | 1.16% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.03M |
| Pretax Income | -6.36M |
| Net Income | -8.72M |
| EBITDA | -6.99M |
| EBIT | -7.03M |
| Earnings Per Share (EPS) | -$4.27 |
Balance Sheet
The company has $20.53 million in cash and n/a in debt, giving a net cash position of $20.53 million or $3.76 per share.
| Cash & Cash Equivalents | 20.53M |
| Total Debt | n/a |
| Net Cash | 20.53M |
| Net Cash Per Share | $3.76 |
| Equity (Book Value) | 20.52M |
| Book Value Per Share | 3.87 |
| Working Capital | 18.66M |
Cash Flow
| Operating Cash Flow | -5.47M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.47M |
| FCF Per Share | -$1.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -403.44% |
| Shareholder Yield | -403.44% |
| Earnings Yield | -125.76% |
| FCF Yield | -78.86% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Aug 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |